Singapore markets closed

MYND Life Sciences Inc. (MYNDF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0249+0.0037 (+17.45%)
At close: 02:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.21M
Enterprise value 3.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.63M
Price/book (mrq)N/A
Enterprise value/revenue 3.39M
Enterprise value/EBITDA -7.30

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 340.68%
S&P500 52-week change 321.33%
52-week high 30.0498
52-week low 30.0152
50-day moving average 30.0215
200-day moving average 30.0210

Share statistics

Avg vol (3-month) 3422
Avg vol (10-day) 31.24k
Shares outstanding 547.82M
Implied shares outstanding 648.97M
Float 833.24M
% held by insiders 159.83%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Oct 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-143.70%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -1.51M
Net income avi to common (ttm)-1.05M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)265
Total cash per share (mrq)0
Total debt (mrq)3M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.12
Book value per share (mrq)-0.11

Cash flow statement

Operating cash flow (ttm)-250.44k
Levered free cash flow (ttm)-966.71k